Table 1

Agonists effective at reducing the amplitude of sAHP in CA3 hippocampal pyramidal cells

AgonistEC501-aEmaxSlope
−log % Inhibition
5-HT (8)5.3 ± 0.1158.2 ± 4.72.6 ± 0.4
5-CT (7)7.5 ± 0.0871.9 ± 7.51.6 ± 0.4
5-MeOT (7)4.8 ± 0.1260.2 ± 6.71.9 ± 0.3

Values are mean ± S.E., and the number of cells is shown in parentheses. WAY-100635 (0.1–1.0 μM) and GR-113808 (0.1 μM) were included in the stock buffer.

  • 1-a  Significant F= 174, P < .001. All comparisons were significantly different.